ECM
EMC Capital Management’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,785
| Closed | -$18K | – | 349 |
|
|
2025
Q1 | $18K | Hold |
14,785
| – | – | 0.01% | 270 |
|
|
2024
Q4 | $27K | Buy |
14,785
+954
| +7% | +$1.74K | 0.02% | 262 |
|
|
2024
Q3 | $265K | Sell |
13,831
-43,654
| -76% | -$836K | 0.17% | 115 |
|
|
2024
Q2 | $68K | Buy |
57,485
+24,785
| +76% | +$29.3K | 0.04% | 252 |
|
|
2024
Q1 | $114K | Buy |
32,700
+20,100
| +160% | +$70.1K | 0.07% | 230 |
|
|
2023
Q4 | $124K | Sell |
12,600
-3,000
| -19% | -$29.5K | 0.08% | 201 |
|
|
2023
Q3 | $126K | Buy |
15,600
+10,251
| +192% | +$82.8K | 0.09% | 193 |
|
|
2023
Q2 | $86 | Sell |
5,349
-2,851
| -35% | -$46 | 0.07% | 230 |
|
|
2023
Q1 | $92K | Buy |
8,200
+6,000
| +273% | +$67.3K | 0.08% | 228 |
|
|
2022
Q4 | $18K | Buy |
2,200
+1,000
| +83% | +$8.18K | 0.02% | 283 |
|
|
2022
Q3 | $12K | Buy |
+1,200
| New | +$12K | 0.01% | 269 |
|